Standout Papers

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppress... 2001 2026 2009 2017 650
  1. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression (2001)
    David G. Burbee, Éva Forgács et al. JNCI Journal of the National Cancer Institute
  2. A gut microbial signature for combination immune checkpoint blockade across cancer types (2024)
    Ashray Gunjur, Yan Shao et al. Nature Medicine

Immediate Impact

11 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Bo Gao being referenced

Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.
2018
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
2001 Standout

Author Peers

Author Last Decade Papers Cites
Bo Gao 746 322 954 78 1.7k
Christian Ensinger 667 314 690 52 1.8k
Alexander C. Klimowicz 647 178 807 55 1.4k
B. Tribukait 473 235 839 88 1.8k
Trevor G. Shepherd 637 187 1105 62 1.7k
Constantina Petraki 556 349 563 63 1.7k
Bristi Basu 794 245 630 84 1.4k
Peter Horak 451 237 1226 66 1.8k
Myrna Candelaria 558 268 1370 85 2.4k
Yoshiyasu Nakamura 523 397 643 70 1.6k
Gloria Peiró 633 178 728 64 1.7k

All Works

Loading papers...

Rankless by CCL
2026